James C. Oates
Ralph H. Johnson VA Medical Center
Charleston
South Carolina
USA
Name/email consistency: high
- Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Oates, J.C., Halushka, P.V., Hutchison, F.N., Ruiz, P., Gilkeson, G.S. Am. J. Med. Sci. (2011)
- The biology of reactive intermediates in systemic lupus erythematosus. Oates, J.C. Autoimmunity (2010)
- Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Oates, J.C., Shaftman, S.R., Self, S.E., Gilkeson, G.S. Arthritis Rheum. (2008)
- Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Oates, J.C., Farrelly, L.W., Hofbauer, A.F., Wang, W., Gilkeson, G.S. Arthritis Rheum. (2007)
- The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Oates, J.C., Gilkeson, G.S. Clin. Immunol. (2006)
- Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. Oates, J.C., Gilkeson, G.S. J. Investig. Med. (2004)
- Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. Oates, J.C., Levesque, M.C., Hobbs, M.R., Smith, E.G., Molano, I.D., Page, G.P., Hill, B.S., Weinberg, J.B., Cooper, G.S., Gilkeson, G.S. J. Rheumatol. (2003)
- Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases. Oates, J.C., Reilly, C.M., Crosby, M.B., Gilkeson, G.S. Arthritis Rheum. (2002)
- Mediators of injury in lupus nephritis. Oates, J.C., Gilkeson, G.S. Curr. Opin. Rheumatol (2002)